Neimeth International Pharmaceutical Plc released its unaudited financial results for the Q4 period ended 30th of September 2021.
- Revenue during the period was N3.05 billion. (+7.31% YoY)
- Cost of sales for the period was N1.60 billion (+20.08% YoY)
- Gross profit stood at N1.45 billion. (-3.94% YoY)
- Operating profit for the period was N412.83 million. (+4.98% YoY)
- Profit before tax of N247.37 million was recorded during the period.
- Profit for the period stood at N336.45 million (+58.35%)
- Total assets during the period stood at N6.33 billion. (-108.23mn YoY)
- Earnings per share of 17.72 kobo Vs 11.00 kobo YoY.
See full result here